Skip to main content
Quest Diagnostics

Analysis of Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Metabolites in Authentic Meconium Samples

AAFS 2026

American Academy of Forensic Science

New Orleans, LA, Feb 9-14, 2026

Oral presentation: Analysis of Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Metabolites in Authentic Meconium Samples

Authors: Marco Ballotari, Michael T. Truver, Bruce A. Goldberger, Sarah H. Bartock, Wen Dui, Kay Roussos-Ross

Medical Specialty: Prescription Drug Monitoring, Toxicology, Women's Health, OB, GYN, Pediatrics

Related content

Conference Presentation
Meconium Marijuana Trends: Prevalence of Delta8-THCCOOH
Audio Podcast
Drug Testing Your Patients for Marijuana
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.